Infantile Spasms

by Dr. Ted Guarino


Note: (The following article does not contain all treatments currently available for treatment of Infantile Spasms).

Infantile spasms (herein "IS") are part of an age-related epilepsy known as West Syndrome. The spasms typically are refractory to anticonvulsants and are associated with a characteristic pattern on EEG known as hypsarrhythmia. Prognosis for normal development is poor; however, early aggressive treatment can maximize the cognitive outcome in these patients.

Since West wrote to Lencet some 153 years ago describing his son’s "…bowing and relaxings…from 10 to 20 or more times at each attack," 1 IS remain one of the most dreaded pediatric diagnoses. The triad of IS, hypsarrhythmia on EEG, and developmental delay has come to be known as West Syndrome. Current anticonvulsant therapy seems to have made little impact on the long-term prognosis of this poorly understood epilepsy.

Ictal Patterns
Variously referred to as jackknife seizures, massive myoclonic seizures, salaam attacks, cheerleader spasms, infantile myoclonic seizures, lightning seizures, or other imaginative descriptions, four ictal patterns of IS are recognized. 2 The flexor spasm consists of rapid flexion at the waist that may be so violent it mimics a jackknife action. If the infant is sitting, this rapid flexion may resemble the salaam greeting. If the infant is supine, brief flexor spasms may resemble sit-ups or abdominal "crunches". The extensor spasm involves a rapid extension of the back and extremities, typically with arm abduction so that the infant may resemble a cheerleader waving pom-poms. The mixed spasm contains components of both flexion and extension. The akinetic spasm is the least common type and consists of sudden loss of motor activity. Most studies report that flexor or mixed spasms are the usual presentation, followed in frequency by extensor and akinetic types. 3-5

The spasms typically present in clusters or flurries of a dozen or more, interspersed by several seconds or minutes of respite. Respiratory changes, crying or laughing, and flushing or other autonomic features may be associated with these seizures. 3

More recently, focal or asymmetric spasms, as well as spasms with focal seizures, have been studied. 6, 7 An asymmetric spasm (one with asymmetric contractions) indicates a focal cerebral lesion or symptomatic origin. The presence of partial seizures concomitant with IS also implies a symptomatic origin and is highly correlated with asymmetric hypsarrhythmia on interictal tracing.

EEG Patterns
In 1952, Gibbs and Gibbs derived the term hypsarrhythmia from the Greek hypsi, meaning high. 8 Hypsarrhythmia describes the chaotic high-amplitude slow waves and spikes that are seen on the interictal EEG usually associated with IS. Gibbs and Gibbs described "random high-voltage slow waves and spikes" as varying from moment to moment, both in duration and location. At times, they appear to be focal, and a few seconds later they seem to originate from multiple foci. Occasionally, the spike discharge becomes generalized, but it never appears as a rhythmically repetitive and highly organized pattern. The abnormality is almost continuous, and in most cases it shows as clearly in the waking as in the sleeping record. It is referred to as hypsarrhythmia. 8

Hrachovy et al studied 24-hour EEG’s of 67 infants with IS and identified some hypsarrhythmia variants. 9 Hypsarrhythmia with increased interhemispheric synchronization (modified hypsarrhythmia) may be a transient feature in a patient’s course not necessarily correlated with a change in prognosis. Asymmetric hypsarrhythmia or hemihypsarrhythmia seems to be associated with porencephaly, agenesis of the corpus calosum, megaloencephaly, or other identifiable cerebral lesions. Hypsarrhythmia with periods of generalized or focal voltage attenuation is most evident during nonrapid eye movement (NREM) sleep and resembles a burst suppression pattern. Brief NREM sleep may produce a semiperiodic grouping of spike and slow wave discharges. REM sleep tends to produce a relative normalization of background activity, with marked reduction of hypsarrhythmia that persists throughout the stage. Arousal from REM or NREM sleep also causes a transient, marked reduction of hypsarrhythmia, lasting seconds to minutes.

The ictal EEG appears to consist of three main patterns, each correlated to a particular spasm. Fusco and Vigevano recorded 955 spasms in 70 infants and described the characteristic EEG pattern of a spasm to be a positive vertex slow wave with medium to high amplitude. 6 The two other patterns correlated with spasms are a medium-amplitude spindle-like activity at 14 to 16 Hz (associated with a clinical stare or akinetic spell) and diffuse attenuation that seems to immediately follow the ictus.

Etiology
The International Classification of Epilepsies and Epileptic Syndromes (1989 Commission) divides West Syndrome into two groups based on etiology: symptomatic and cryptogenic. Symptomatic cases have a prior history of brain injury (clinically or radiographically) or known etiology. Cryptogenic cases have no prior signs of brain injury or known etiology. A review of the literature shows the proportion of cryptogenic cases of IS has decreased over time from "50% to approximately 30%," attributable to improved diagnostic techniques.

Causes of IS among symptomatic patients may include virtually any brain disturbance expressed prenatally, perinatally, or postnatally. In a retrospective study of 363 infants with IS, Lombroso found 165 symptomatic cases. 3 He identified prenatal etiologies in 49% (including dysgenetic, chromosomal, and hypoxic-ischemic injury): perinatal etiologies in 24% (obstetric trauma, acidosis, fetal-heart deceleration with hypoxic-ischemia): and postnatal etiologies in 30% (including metabolic, hemorrhagic, and infectious). More recently, Ohlahara et al reviewed 162 symptomatic cases and found a similar high percentage of prenatal causes (47%).12 The single most common identifiable etiology in both studies was tuberous sclerosis (11% in Lombroso, 14% in Ohlahara et al).

In the past year, Vegevano et al proposed a third subgroup of patients with West Syndrome: those with no known or suspected etiology other than possible hereditary predisposition, based on family history or EEG genetic traits. 13 Recent studies indicate that this "idiopathic" form may represent 10% to 15% of cases of West Syndrome 12, 13 and often is associated with a good neurologic outcome.

Neuropathologic findings reflect the diverse etiologies of West Syndrome. Jellinger reviewed 264 autopsies of infants with IS and identified 5 morphologically distinct groups in descending order of occurrence: embryofetal lesions, including agyria, micropolygyria, agenesis of the corpus callosum, heterotopias, cortical dysplasia, tuberous sclerosis, and metabolic disorders, such as lipidosas and leukodystrophies; perinatal and postnatal encephalopathies, including white-matter scars and lobar and hippocunpal sclerosis; combined developmental and perinatal and postnatal lesions, such as interdysplasias with secondary anoxic changes; acute vascular or inflammatory injuries; and no pathology. 14 Vinters et al found two major identifiable abnormalities among cortical tissue resected during surgery for IS: cystic-gliotic encephalomalacia seen in destructive lesions and dysplastic changes, such as bizarre gemistocytic "balloon" cells, and secondary cytoskeletal changes, as may be seen in tuberous sclerosis. 15

Genetics
West Syndrome is an age-related epilepsy syndrome that seems to have a peak incidence at approximately 5 months, with a range from birth to 24 months. 16 A male preponderance of 2:1 has been reported. 17

Because other epilepsy syndromes have a familial recurrence, and the male-to-female ratio suggests a sex-linked trait, the risk of recurrence of West Syndrome has been studied. The incidence of IS is approximately .24 cases per 1,000 livebirths. 17 Fleiszar and colleagues studied pedigrees of 77 cases of West Syndrome and estimated the empiric risk of recurrence among siblings was 15/1,000, and 7/1,000 for first-degree relatives. 18 They cautioned that West Syndrome is multifactorial, and certain cases may have polygenic susceptibility or may be completely environmental. Their study failed to confirm a male preponderance.

More recently, Dulac et al studied familial antecedents of 223 cases of West Syndrome and found that after excluding those with an identifiable predisposing factor (i.e., twin gestation with prematurity, tuberous sclerosis, or recurrent maternal toxemia), the risk of recurrence among siblings approached that of the general population. 19 Even without excluding the known predisposing factors, the risk of recurrence for siblings remained less than 2%.

Diagnostic Investigations
Routine blood and spinal fluid evaluations will be normal unless an underlying infection or metabolic disorder is present. Tests should be directed to the suspected etiology of the individual patient. In addition to the EEG, neuroimaging or even functional neuroimaging has proven useful in determining the etiology or evaluating the patient for surgical resection.

Computerized tomography (CT) has been shown to detect pathology in 75% to 90% of cases of West Syndrome 20, with better results as technology improved. Ludwig studied 51 patients with West Syndrome via CT before coticotropin (ACTH) therapy and found 21% had embryofetal lesions (cerebral malformations); 57% had evidence of perinatal and postnatal injury (encephalomacia, hypoxic-ischemic necrosis, or inflammatory lesions); 12% had both embryofetal and perinatal and postnatal lesions; and 10% were normal. 21

Magnetic resonance imaging (MRI) has been demonstrated to be more sensitive than CT in detecting lesions in patients with partial seizures. 22 Recently, MRI also has been shown to be more sensitive than CT in detecting lesions in approximately 5% to 10% of cases of West Syndrome with unknown etiology, especially regarding abnormal myelination and focal corticosubcortical lesions. 23

Functional neuroimaging is emerging as an important tool in the preoperative evaluation of patients with West Syndrome. Interictal singe-photon emission computed tomography (SPECT) has shown that hypoperfused foci at the onset of IS appear to correlate with EEG foci. 24 Chugani et al described four patients with cryptogenic West Syndrome who had normal MRI scans but had focal hypometabolism on positron emission tomography (PET). 25 These infants underwent successful surgical resection, and the pathology showed microscopic cortical dysplasia.

Treatment
IS are poorly responsive to most conventional anticonvulsants. The drugs that do have some activity against IS are a diverse group but appear to share some agonist properties for gamma-amniobutyric acid (GABA) – an inhibitory neurotransmitter.

Benzodiazepines often are effective initially in up to 40% to 50% of patients with West Syndrome26 but may cause unacceptable sedation and tolerance months later. Dreifuss and colleagues reported an initial equivalent response between nitrazepam and ACTH over a four-week period. 27 Our experience at Stanford also has shown nitrazepam to be superior to the other benzodiazepines; however, oversedation, secretion aspiration, and eventual drug tolerance were seen. Benzodiazepines are known to facilitate GABA-mediated synaptic inhibition. 28

Valproate, at high doses (up to 100 mg/kg/day), has been shown to be effective in up to two-thirds of cases of IS in short-term trials. Valproate is known to inhibit GABA metabolism, thus increasing cerebrospinal fluid GABA levels.

High-dose pyridoxine (vitamin B6), 200 to 400 mg/kg/day, also has been studied in the treatment of IS. A recent series of 17 patients with West Syndrome showed 5 responded to pyridoxine, 300 mg/kg/day, within 2 weeks. 30 A pyridoxal phosphate (vitamin B6 metabolite)-dependent enzyme is involved in the synthesis of GABA; when this enzyme is supplemented, an increase in cerebrospinal fluid levels of GABA may occur.

Based on anecdotal remissions of refractory seizures after viral infections and immunoglobulin (Ig) injections, Ig therapy has been studied in the treatment of IS. Ariizumi et al administered intravenous Ig (97% IgG and 3% IgA) at 100 to 200 mg/kg every 2 to 3 weeks for 6 to 10 doses. 31 They found complete remission among all six patients studied with cryptogenic West Syndrome. The mechanism is unknown.

Vigabatrin (gamma-vinyl-GABA) is a new anticonvulsant agent that inhibits GABA-transminase, thus increasing cerebrospinal fluid levels of GABA. 32 Recently, 2 small studies showed a 50% to 80% early response (within 1 to 2 weeks) in patients with West Syndrome treated with Vigabatrin. 33, 34 Divided doses were used, from 50 to 200 mg/kg/day. Reported side effects included agitation, sedation, and hypotonia in up to 40% of patients.

Felbamate (Felbatol), a carbamate derivative recently approved by the FDA, has been shown to have activity against the refractory mixed seizures of Lennox-Gastaut Syndrome. A study of felbamate in the treatment of Lennox-Gastaut Syndrome has shown a 34% reduction in frequency of atonic seizures.35 Encouraged by these results, others have begun using felbamate for refractory spasms. In a small, ongoing series, Shields (personal communication) expects 10% to 20% of patients with IS to obtain a good response to felbamate, similar to our experience at Stanford. Divided doses are increased gradually to approximately 50 to 60 mg/kg/day, or until the appearance of unacceptable side effects (e.g., agitation, anorexia, and sleep disturbance).

The most effective therapy for IS was discovered by Sorel and Dusaucy-Bauloye in 1958. 36 Intramuscular ACTH remains the standard by which other treatments of IS are judged. Various dosing schemes have been proposed, but our experience at Stanford seems to support Snead’s recommendation of high-dose ACTH (up to 150 U/m2/day).37 Studies of ACTH often compare efficacy to high-dose prednisone (2 mg/kg/day). Steroids also have been shown to be effective in the early control of IS; Hrachovy et al have even shown equivalency between low-dose ACTH (20 U/day) and high-dose prednisone. 38 However, Snead and colleagues have shown that high-dose ACTH achieved control of spasms in 90% of cases, versus 40% with high-dose prednisone. 39, 40 Another comparison of high-dose ACTH versus high-dose prednisone showed ACTH was associated with better developmental outcome and decreased frequency of other seizure types among 72 patients with cryptogenic West Syndrome over a six-year period. 3 Furthermore, infants who received ACTH within one month of spasm onset had better developmental outcome and seizure control than those in whom treatment was delayed. 3

Based ont hese data, early high-dose ACTH should be instituted in hope of earlier spasm control and better cognitive outcome. At our institution, the patient may be admitted overnight or evaluated in the day-hospital setting to obtain baseline laboratory tests (e.g., blood count, urinalysis, glucose, electrolytes, and renal and hepatic function panels) and to teach intramuscular injection to caretakers. ACTH gel, at 20 U/day intramuscularly, is begun, with a rapid increase to 150 U/m2/day over 2 to 3 weeks if no response is seen. The peak dose is maintained over 4 to 6 weeks and then tapered off to complete a 10 to 12-week course. Prophylactic trimethoprim-sulfamethoxazole is also given to minimize opportunistic infection. Weekly follow-up is obtained initially to monitor blood pressure, glucosuria, and general health. Should relapse occur during or after the course of ACTH, a second trial is sometimes effective. Oral prednisone, 2 mg/kg/day in divided doses, provides a simpler and somewhat safer alternative. The same baseline laboratory tests are obtained, and the steroid is given over ten weeks with gradual taper. Reversible side effects are common in both regimens and include cushingoid features, hypertension, glucose intolerance, irritability, and cerebral atrophy. Cardimyopathy and sepsis are the more serious complications and demand clinical vigilance.

The mechanism by which steroid hormones inhibit IS is not known. However, some neuroactive effects are recognized, 41 including enhanced myelin formation, which may expedite a critical stage of brain maturation; stabilization of cell membranes, including hyperpolarization of neurons; increased integrity of the blood-brain barrier; and enhanced midbrain and striatal GABA-receptor binding.

Corticotropin-releasing hormone (CRH) in an excitatory neuropeptite with potent convulsant properties in infant rats. 42 This gene expression in rats seems to correlate with the age specificity of IS 43, and is induced by injury or stress. ACTH and glucocorticoids provide feedback suppression of CRH synthesis. Baram proposed that stress-induced increases in CRH activity during a critical time may be responsible for IS, 44 accounting for the age specificity of the disease as well as the unique response to ACTH and prednisone.

Surgery is an emerging therapy for refractory spasms. Chugani et al described 23 cases of refractory spasms: 23 by EEG and PET localization and 7 by MRI localization. 45 Following the cortical resection or hemispherectomy, 15 children were free of seizures, 4 had a greater than 75% seizure reduction, and 4 had no seizure improvement (mean follow-up was 28 months).

Natural History
Approximately 75% to 90% of infants with spasms will have moderate-to-severe developmental delay. 3, 46 Although 90% will be free of spasms by 5 years of age, 50% to 60% will have developed other seizure types, including tonic-clonic and myoclonic seizures. 11, 47 Of infants with spasms, 10% to 50% will develop Lennox-Gastaut Syndrome (slow spike-wave EEG pattern, mixed seizures, and developmental delay). 3, 5 Despite the statistical association between West Syndrome and Lennox-Gastaut Syndrome, they appear to be distinct entities that usually have in common sever underlying brain injury.

Attempts have been made to identify West Syndrome populations with improved outcomes. Most studies have shown the best outcomes in the cryptogenic group, with normal development seen in 30% to 70% of these infants. 11, 45 In contrast, the symptomatic group has a 5% to 25% incidence of normal development, with an increased risk of subsequent refractory seizures as well. 3, 11 The more apparent pathology seen in symptomatic patients is presumed to be responsible for this discrepancy.

Riikonen identified five factors associated with improved outcome: later age of onset (older than 5 months), prior normal development, early treatment (less than one month after spasm onset), shorter duration of spasms, and lack of preceding seizures. 48 Plouin et al recently have shown the presence of concomitant partial seizures, asymmetric hypsarrhythmia, and focal spasms belies a poor prognosis. 7, 49

Summary
West Syndrome is an age-specific epilepsy with multiple diverse etiologies. Although the pathogenesis remains unknown, a subgroup can be identified with improved prognosis. Early, aggressive ACTH therapy is associated with a better outcome, perhaps by virtue of earlier spasm control. Promising therapies include emerging anticonvulsants and surgical resection in carefully selected patients.


-Dr. Guarino is a First-Year Epilepsy Fellow and Clinical Instructor in the Department of Neurology at Stanford, California. He received his medical degree in 1986 from Loyola-Stritch School of Medicine in Chicago, Illinois.


Click here to refer to Dr. Guarino's endnotes from the above article.

 

 

Hosted by www.Geocities.ws

1